HRP20110028T1 - NOVA KOMBINACIJA INHIBITORA SINUSOIDNE STRUJE If I SREDSTVA ZA BLOKIRANJE KALCIJEVIH KANALA TE FARMACEUTSKI PRIPRAVCI KOJI SADRŽE NAVEDENU KOMBINACIJU - Google Patents

NOVA KOMBINACIJA INHIBITORA SINUSOIDNE STRUJE If I SREDSTVA ZA BLOKIRANJE KALCIJEVIH KANALA TE FARMACEUTSKI PRIPRAVCI KOJI SADRŽE NAVEDENU KOMBINACIJU Download PDF

Info

Publication number
HRP20110028T1
HRP20110028T1 HR20110028T HRP20110028T HRP20110028T1 HR P20110028 T1 HRP20110028 T1 HR P20110028T1 HR 20110028 T HR20110028 T HR 20110028T HR P20110028 T HRP20110028 T HR P20110028T HR P20110028 T1 HRP20110028 T1 HR P20110028T1
Authority
HR
Croatia
Prior art keywords
pharmaceutical preparation
hydrates
preparation according
crystalline forms
association
Prior art date
Application number
HR20110028T
Other languages
English (en)
Croatian (hr)
Inventor
Benatar Vidal
Lerebours-Pigeonniere Guy
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37075950&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20110028(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of HRP20110028T1 publication Critical patent/HRP20110028T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HR20110028T 2005-12-21 2011-01-17 NOVA KOMBINACIJA INHIBITORA SINUSOIDNE STRUJE If I SREDSTVA ZA BLOKIRANJE KALCIJEVIH KANALA TE FARMACEUTSKI PRIPRAVCI KOJI SADRŽE NAVEDENU KOMBINACIJU HRP20110028T1 (hr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0513008A FR2894826B1 (fr) 2005-12-21 2005-12-21 Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur calcique et les compositions pharmaceutiques qui la contiennent

Publications (1)

Publication Number Publication Date
HRP20110028T1 true HRP20110028T1 (hr) 2011-02-28

Family

ID=37075950

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20110028T HRP20110028T1 (hr) 2005-12-21 2011-01-17 NOVA KOMBINACIJA INHIBITORA SINUSOIDNE STRUJE If I SREDSTVA ZA BLOKIRANJE KALCIJEVIH KANALA TE FARMACEUTSKI PRIPRAVCI KOJI SADRŽE NAVEDENU KOMBINACIJU

Country Status (41)

Country Link
US (3) US20070142356A1 (de)
EP (1) EP1800683B1 (de)
JP (2) JP4783275B2 (de)
KR (1) KR100907584B1 (de)
CN (1) CN101015556B (de)
AP (1) AP2208A (de)
AR (1) AR058575A1 (de)
AT (1) ATE488239T1 (de)
AU (1) AU2006252211B2 (de)
BR (1) BRPI0605516A (de)
CA (1) CA2571649C (de)
CO (1) CO5790167A1 (de)
CR (1) CR8813A (de)
CY (1) CY1111007T1 (de)
DE (1) DE602006018247D1 (de)
DK (1) DK1800683T3 (de)
EA (1) EA013536B1 (de)
ES (1) ES2356660T3 (de)
FR (1) FR2894826B1 (de)
GE (1) GEP20094603B (de)
GT (1) GT200600523A (de)
HR (1) HRP20110028T1 (de)
IL (1) IL180209A (de)
JO (1) JO2675B1 (de)
MA (1) MA28724B1 (de)
MX (1) MXPA06014884A (de)
MY (1) MY143563A (de)
NO (1) NO337509B1 (de)
NZ (1) NZ552222A (de)
PE (1) PE20071133A1 (de)
PL (1) PL1800683T3 (de)
PT (1) PT1800683E (de)
PY (1) PY0639427A (de)
RS (1) RS51534B (de)
SA (1) SA06270482B1 (de)
SG (1) SG133546A1 (de)
SI (1) SI1800683T1 (de)
TW (1) TWI373344B (de)
UA (1) UA91507C2 (de)
WO (1) WO2007077329A2 (de)
ZA (1) ZA200610822B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2894826B1 (fr) * 2005-12-21 2010-10-22 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur calcique et les compositions pharmaceutiques qui la contiennent
FR2920773B1 (fr) 2007-09-11 2009-10-23 Servier Lab Derives de 1,2,4,5-tetrahydro-3h-benzazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2927538B1 (fr) * 2008-02-14 2010-02-19 Servier Lab Association d'un inhibiteur du courant if sinusal et d'un beta-bloquant.
CN101564394B (zh) * 2008-04-21 2010-12-15 鲁南制药集团股份有限公司 含有伊伐布雷定和曲美他嗪的药物组合物
WO2009158005A1 (en) * 2008-06-27 2009-12-30 Concert Pharmaceuticals, Inc. Benzazepinone compounds
FR2938194B1 (fr) * 2008-11-07 2012-08-31 Servier Lab Utilisation de l'ivabradine comme agent de diagnostic dans la methode d'angiographie coronaire par tomodensitometrie multicoupe
RU2392940C1 (ru) * 2009-03-23 2010-06-27 Государственное образовательное учреждение дополнительного профессионального образования Санкт-Петербургская медицинская академия последипломного образования Федерального агентства по здравоохранению и социальному развитию Способ лечения брадиаритмии, вызванной атриовентрикулярными блокадами

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8608335D0 (en) * 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
US20030092745A1 (en) * 2000-02-25 2003-05-15 Pfizer Inc. Combination therapy
WO2003024457A1 (en) * 2001-09-11 2003-03-27 Asahi Kasei Kabushiki Kaisha Medicinal composition for prevention of or treatment for cerebrovascular disorder and cardiopathy
AR037565A1 (es) * 2001-11-21 2004-11-17 Synthon Bv Formas de sales de amlodipina y procedimientos para prepararlas.
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2894826B1 (fr) * 2005-12-21 2010-10-22 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur calcique et les compositions pharmaceutiques qui la contiennent

Also Published As

Publication number Publication date
SI1800683T1 (sl) 2011-01-31
TWI373344B (en) 2012-10-01
ES2356660T3 (es) 2011-04-12
JO2675B1 (en) 2012-06-17
US20110230466A1 (en) 2011-09-22
PY0639427A (es) 2013-04-01
MXPA06014884A (es) 2009-02-11
AR058575A1 (es) 2008-02-13
FR2894826B1 (fr) 2010-10-22
JP2007169284A (ja) 2007-07-05
HK1106442A1 (en) 2008-03-14
IL180209A0 (en) 2008-01-20
CY1111007T1 (el) 2015-06-11
ATE488239T1 (de) 2010-12-15
FR2894826A1 (fr) 2007-06-22
US20070142356A1 (en) 2007-06-21
AU2006252211A1 (en) 2007-07-05
WO2007077329A3 (fr) 2007-09-07
DK1800683T3 (da) 2011-03-07
KR100907584B1 (ko) 2009-07-14
CR8813A (es) 2007-06-06
MY143563A (en) 2011-05-31
AU2006252211B2 (en) 2012-05-17
NO337509B1 (no) 2016-05-02
ZA200610822B (en) 2008-06-25
EA013536B1 (ru) 2010-06-30
RS51534B (sr) 2011-06-30
CN101015556B (zh) 2011-08-10
NO20065903L (no) 2007-06-22
EP1800683A1 (de) 2007-06-27
GEP20094603B (en) 2009-02-10
JP2011068661A (ja) 2011-04-07
CA2571649C (fr) 2012-05-22
WO2007077329A2 (fr) 2007-07-12
KR20070066922A (ko) 2007-06-27
CN101015556A (zh) 2007-08-15
MA28724B1 (fr) 2007-07-02
SG133546A1 (en) 2007-07-30
US20090215745A1 (en) 2009-08-27
CO5790167A1 (es) 2007-08-31
PL1800683T3 (pl) 2011-04-29
DE602006018247D1 (de) 2010-12-30
BRPI0605516A (pt) 2007-10-16
AP2006003858A0 (en) 2006-12-31
JP4783275B2 (ja) 2011-09-28
GT200600523A (es) 2007-07-25
PE20071133A1 (es) 2007-12-22
TW200744637A (en) 2007-12-16
PT1800683E (pt) 2010-12-17
NZ552222A (en) 2008-05-30
EP1800683B1 (de) 2010-11-17
CA2571649A1 (fr) 2007-06-21
AP2208A (en) 2011-02-23
EA200602156A1 (ru) 2007-08-31
UA91507C2 (ru) 2010-08-10
IL180209A (en) 2015-05-31
SA06270482B1 (ar) 2011-06-22

Similar Documents

Publication Publication Date Title
MA28626B1 (fr) Forme cristalline delta du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882555B1 (fr) Forme cristalline gamma du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
EE05195B1 (et) Kinoliini ja kinolinooni derivaadid glutamaatretseptori antagonistidena, nende saamine ja kasutamine ravimite valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
FR2882556B1 (fr) Forme cristalline gamma d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
HUP0302656A3 (en) Fumaric acid amides, their use for preparation of pharmaceutical compositions and pharmaceutical compositions containing the compounds
PE20030399A1 (es) Formas de administracion de propiverina o sus sales farmaceuticamente aceptables con liberacion prolongada de la sustancia activa
CA2448035A1 (en) New pharmaceutical composition
HUP0203836A3 (en) 1,3-disubstituted pyrrololidines as alpha-2-adrenoceptor antagonists, process for their preparation and pharmaceutical compositions containing them and their use
ATE522251T1 (de) Toilettenartikel enthaltend eine geordnete wirkstoffabgebende zubereitung und ein verabreichungsvehikel
IL154053A0 (en) AZA-BRIDGED-BICYCLIC AMINO ACID DERIVATIVES AS alpha4 INTEGRIN ANTAGONISTS
HUP0202757A3 (en) Heteropolycyclic compounds, pharmaceutical compositions containing them and their use as metabotropic glutamate receptor antagonists
HUP0302456A3 (en) Combination pharmaceutical compositions containing of amlodipine and benazepril and their use and preparation
HRP20110532T1 (hr) Kombinacija inhibitora if struje sinusnog čvora i inhibitora enzima konverzije angiotenzina
HUP0100865A3 (en) Meta-azacyclic amino benzoic acid compounds and derivatives thereof being integrin antagonists, pharmaceutical compositions comprising thereof and their use
HUP0402129A3 (en) Crystalline hydrates of nicotinic acid anilide and benzoyl anilide derivatives, preparation thereof, compositions containing the same and processes for their use
EP1322158A4 (de) Metformin enthaltende pharmazeutische zusammensetzungen mit verzögerter wirkstofffreigabe und verfahren zu ihrer herstellung
EE200300234A (et) Bifenüülkarboksamiidühendite kasutamine lipiiditaset alandavate toimeainetena, meetod nende valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
NO20050888D0 (no) Ny fremgangsmate for syntesen av 1,3,4,5-tetrahydro-2H-3-benzazepin-2-onforbindelser, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre
CO5790167A1 (es) Nueva asociacion de un inhibidor de la corriente sinusal if y de un inhibidor calcico y las composiciones farmaceuticas que las contienen
FR2834896B1 (fr) Composition pharmaceutique orodispersible d'ivabradine
BR0116558A (pt) Composição farmacêutica em comprimido, base livre de amilodipina, método de tratamento ou prevenção de hipertensão, angina ou congestão cardìaca, processo, processo para purificação de base livre de amlodipina e população base livre de amlodipina em partìculas
EA200800022A3 (ru) Применение ивабрадина для получения лекарственного средства, предназначенного для лечения эндотелиальной дисфункции
RU2006140988A (ru) Фармацевтические композиции, содержащие соль миртазапина
FR2826651B1 (fr) Forme cristalline d'une phenylethanolamine, sa preparation et compositions pharmaceutiques la contenant
EE200200043A (et) B-grupi streptogramiinide derivaadid, nende valmistamismeetod, farmatseutiline kompositsioon ja segu